Skip to main navigation Skip to search Skip to main content

Management of malignant bowel obstruction in terminal care--is home care possible?

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Malignant bowel obstruction occurs in about 10% of those with advanced abdominal cancer and in about 25% of those with advanced pelvic cancer. Such patients usually develop nausea, vomiting, constipation, abdominal dilatation and colicky pain. Traditional therapy consists of intravenous fluids and decompression by duodenal tube, gastrostomy or operation but postoperative mortality is high. Treatment requires hospitalization and therefore such patients have not been considered candidates for home care. Palliative medical techniques can cope with this syndrome and allow home care. Hypodermoclysis, non-prokinetic antiemetics like haloperidol and scopolamine, octeotride, corticosteroids, and narcotics for severe abdominal pain can alleviate symptoms. Medications can be combined and infused subcutaneously in a syringe driver and patients can remain with their families in their natural environment. Such techniques can give these patients who have short life expectancies reasonable quality of life.

Original languageEnglish
Pages (from-to)757-759, 832
JournalHarefuah
Volume134
Issue number10
StatePublished - 1 Jan 1998
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Management of malignant bowel obstruction in terminal care--is home care possible?'. Together they form a unique fingerprint.

Cite this